Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
A phase 2 study of reduced therapy for newly diagnosed average-risk WNT-driven medulloblastoma patients
Protocol ID
ACNS1422
Disease (Sub Disease)
Medulloblastoma
Diagnosis Stage
New diagnosis
Location
NSW, WA, SA
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Links
Trial Status
Open
Sites
John Hunter Children's Hospital
Perth Children's Hospital
Women's & Children's Hospital
Perth Children's Hospital
Women's & Children's Hospital
Study Type
Treatment
Phase
Phase 2
Age Eligibility
3 years to 22 years at the time of enrollment
International registry ID's
NCT02724579
| Study Title | A phase 2 study of reduced therapy for newly diagnosed average-risk WNT-driven medulloblastoma patients |
|---|---|
| Protocol ID | ACNS1422 |
| Disease (Sub Disease) | Medulloblastoma |
| Diagnosis Stage | New diagnosis |
| Location | NSW / WA / SA |
| Sponsor | Children's Oncology Group |
| Collaborators | National Cancer Institute (NCI) |
| Links | https://clinicaltrials.gov/ct2/show/NCT02724579 |
| Trial Status | Open |
| Sites | John Hunter Children's Hospital / Perth Children's Hospital / Women's & Children's Hospital/ |
| Study Type | Treatment |
| Phase | Phase 2 |
| Age Eligibility | 3 years to 22 years at the time of enrollment |
| International registry ID's | NCT02724579 |